Lister Troy bought VERV
January 8, 2025 · Form 4 insider transaction
Lister Troy bought 225,000 shares of Verve Therapeutics Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
225,000
Price
$0.00
Total value
N/A
InsiderLister Troy
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 8, 2025
Filing dateJanuary 10, 2025
Shares owned after225,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option was granted on January 8, 2025. 25% of the shares underlying the option will vest on January 8, 2026, and the remainder are scheduled to vest in equal monthly installments thereafter until January 8, 2029.